Laurus Labs Limited (LAURUSLABS.BO)
INR 571.2
(0.69%)
INR 571.2
(0.69%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 25.77 Billion INR | 27.9% |
| 2022 | 20.15 Billion INR | 13.42% |
| 2021 | 17.76 Billion INR | 19.91% |
| 2020 | 14.81 Billion INR | 37.27% |
| 2019 | 10.79 Billion INR | 4.2% |
| 2018 | 10.35 Billion INR | 5.72% |
| 2017 | 9.79 Billion INR | 16.41% |
| 2016 | 8.41 Billion INR | -18.09% |
| 2015 | 10.27 Billion INR | 25.55% |
| 2014 | 8.18 Billion INR | 50.8% |
| 2013 | 5.42 Billion INR | 85.39% |
| 2012 | 2.92 Billion INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 27.21 Billion INR | 0.0% |
| 2023 Q4 | 25.77 Billion INR | 0.0% |
| 2023 Q2 | 21.34 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 25.77 Billion INR | 27.9% |
| 2022 Q2 | 20.94 Billion INR | 0.0% |
| 2022 Q4 | 20.15 Billion INR | 0.0% |
| 2022 FY | 20.15 Billion INR | 13.42% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q2 | 17.64 Billion INR | 0.0% |
| 2021 FY | 17.76 Billion INR | 19.91% |
| 2021 Q4 | 17.76 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q4 | 14.81 Billion INR | 0.0% |
| 2020 FY | 14.81 Billion INR | 37.27% |
| 2020 Q2 | 10.82 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q4 | 10.79 Billion INR | 0.0% |
| 2019 FY | 10.79 Billion INR | 4.2% |
| 2019 Q2 | 11.44 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 10.35 Billion INR | 0.0% |
| 2018 FY | 10.35 Billion INR | 5.72% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 11.92 Billion INR | 0.0% |
| 2017 Q2 | 10.47 Billion INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 9.79 Billion INR | 0.0% |
| 2017 FY | 9.79 Billion INR | 16.41% |
| 2016 Q2 | 11.24 Billion INR | 0.0% |
| 2016 FY | 8.41 Billion INR | -18.09% |
| 2016 Q4 | 8.41 Billion INR | 0.0% |
| 2016 Q1 | - INR | 0.0% |
| 2015 FY | 10.27 Billion INR | 25.55% |
| 2014 FY | 8.18 Billion INR | 50.8% |
| 2013 FY | 5.42 Billion INR | 85.39% |
| 2012 FY | 2.92 Billion INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Ajanta Pharma Limited | 352.8 Million INR | -7205.556% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -149029.202% |
| Sigachi Industries Limited | 1.43 Billion INR | -1701.726% |
| Bal Pharma Limited | 1.39 Billion INR | -1745.635% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -15406.329% |
| Medico Remedies Limited | 80.5 Million INR | -31915.8% |
| Lasa Supergenerics Limited | 220.76 Million INR | -11575.017% |
| Venus Remedies Limited | 413.3 Million INR | -6136.148% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -4114.881% |
| Alpa Laboratories Limited | 52.46 Million INR | -49026.084% |
| Nectar Lifesciences Limited | 6.35 Billion INR | -305.547% |
| Shilpa Medicare Limited | 9.37 Billion INR | -174.955% |
| Aarti Drugs Limited | 5.64 Billion INR | -356.767% |
| Lupin Limited | 29.21 Billion INR | 11.786% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 61.228% |
| Zydus Lifesciences Limited | 8.04 Billion INR | -220.492% |
| Windlas Biotech Limited | 36.41 Million INR | -70688.245% |
| Suven Life Sciences Limited | 7.09 Million INR | -363067.536% |
| Eris Lifesciences Limited | 27.81 Billion INR | 7.33% |
| Valiant Laboratories Limited | 767.08 Million INR | -3259.997% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | -582.466% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | -154.81% |
| Ipca Laboratories Limited | 14.38 Billion INR | -79.19% |
| Bliss GVS Pharma Limited | 998.4 Million INR | -2481.528% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 21.269% |
| Bajaj HealthCare Limited | 3.32 Billion INR | -674.403% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Mankind Pharma Limited | 2.07 Billion INR | -1144.085% |
| Piramal Pharma Limited | 47.1 Billion INR | 45.28% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -3455.692% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 35.917% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | -402.261% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | -109.386% |
| Unichem Laboratories Limited | 2.47 Billion INR | -941.314% |
| Sequent Scientific Limited | 4.87 Billion INR | -428.488% |
| Novartis India Limited | 69.7 Million INR | -36878.479% |
| Wanbury Limited | 1.16 Billion INR | -2112.653% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -3865.45% |
| Wockhardt Limited | 23.56 Billion INR | -9.397% |
| Themis Medicare Limited | 957.92 Million INR | -2590.616% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -28726.753% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 29.656% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -14930.324% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | -28.741% |
| Divi's Laboratories Limited | 30 Million INR | -85813.333% |
| NATCO Pharma Limited | 3.71 Billion INR | -594.343% |
| Gufic Biosciences Limited | 3.32 Billion INR | -674.19% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -7767.521% |
| Ind-Swift Limited | 10.13 Billion INR | -154.183% |
| Procter & Gamble Health Limited | 95.6 Million INR | -26860.251% |
| FDC Limited | 205.18 Million INR | -12461.347% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -1232.475% |
| Granules India Limited | 13.15 Billion INR | -95.99% |
| Medicamen Biotech Limited | 308.17 Million INR | -8263.511% |
| Alkem Laboratories Limited | 14.18 Billion INR | -81.711% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -55952.368% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -587140.829% |
| Brooks Laboratories Limited | 56.41 Million INR | -45583.192% |
| Megasoft Limited | 1.47 Billion INR | -1652.773% |
| ZIM Laboratories Limited | 1.08 Billion INR | -2268.403% |
| Strides Pharma Science Limited | 25.16 Billion INR | -2.405% |
| Neuland Laboratories Limited | 953.89 Million INR | -2601.972% |
| Morepen Laboratories Limited | 289.99 Million INR | -8787.831% |
| Hikal Limited | 8.17 Billion INR | -215.247% |
| Indoco Remedies Limited | 6.71 Billion INR | -283.564% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | -803.558% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -8044.345% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -2516.849% |
| Hester Biosciences Limited | 2.44 Billion INR | -954.678% |